Status:
COMPLETED
Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial
Lead Sponsor:
King's College London
Conditions:
Paranoia in People With Schizophrenia-spectrum Diagnosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
People with a schizophrenia spectrum diagnosis often experience distressing worries or beliefs about others intending to cause them harm (also known as paranoia). Paranoid beliefs are associated with ...
Eligibility Criteria
Inclusion
- Self reported worries about being harmed or at risk from others
- Non-affective psychosis(ICD10,F20-F29)
- Age 18-65
- Symptoms stable no major relapse or crisis in last 3 months prior to consent
- Sufficient command of English to provide informed consent, complete the measures and participate in the brief interventions
- Score above the cutoff for clinically significant levels of paranoia on the Green Paranoid Thoughts Scale (Green et al, 2008)
- Paranoia is triggered by being outside
Exclusion
- Lack of capacity to provide informed consent
- Primary diagnosis of drug or alcohol use with secondary psychosis
- Primary diagnosis of mood disorder or bipolar affective disorder
- Primary diagnosis of learning difficulty
- Unstable residential arrangements (making a move away during the course of participation in the research likely)
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01920685
Start Date
January 1 2014
End Date
October 1 2016
Last Update
March 20 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxleas NHS Foundation Trust
Dartford, Kent, United Kingdom, DA2 7WG
2
South London & Maudsley NHS Foundation Trust
London, London, United Kingdom, SE5 8AF